This is a Randomised, Open-labeled, Multi-center Study to Investigate the Safety and Efficacy of OROS Hydromorphone HCL Comparing With Morphine SR (Sustain Release) in Cancer Pain Patients.

This study is not yet open for participant recruitment.

Study NCT00803283 Information provided by Johnson & Johnson Taiwan Ltd

First Received: December 4, 2008 Last Updated: August 27, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is not yet open for participant recruitment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given